- A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells
Bei Zhao et al, 2020, Frontiers in Pharmacology CrossRef - Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
Jun Lu et al, 2019, Frontiers in Oncology CrossRef - Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
Xiaoming Huang et al, 2021, Current Pharmaceutical Biotechnology CrossRef - Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
Jun Lu et al, 2019, BMC Medical Genomics CrossRef - Integrative RNA-Seq and ATAC-Seq Analysis Reveals the Migration-Associated Genes Involved in Antitumor Effects of Herbal Medicine Feiyanning on Lung Cancer Cells
Chenyang Wang et al, 2021, Frontiers in Genetics CrossRef